Nepetoidin B Alleviates Liver Ischemia/Reperfusion Injury via Regulating MKP5 and JNK/P38 Pathway

References

• Saidi R, Kenari S. Liver ischemia/reperfusion injury: an overview. J Invest Surg. 2014;27(6):366–379. doi:10.3109/08941939.2014.932473
   PubMed Web of Science ®Google Scholar
• Nastos C, Kalimeris K, Papoutsidakis N, et al. Global consequences of liver ischemia/reperfusion injury. Oxid Med Cell Longev. 2014;2014:906965. doi:10.1155/2014/906965
   PubMed Web of Science ®Google Scholar
• Quesnelle K, Bystrom P, Toledo-Pereyra L. Molecular responses to ischemia and reperfusion in the liver. Arch Toxicol. 2015;89(5):651–657. doi:10.1007/s00204-014-1437-x
   PubMed Web of Science ®Google Scholar
• Liu J, Man K. Mechanistic insight and clinical implications of ischemia/reperfusion injury post liver transplantation. Cell Mol Gastroenter. 2023;15(6):1463–1474. doi:10.1016/j.jcmgh.2023.03.003
   PubMed Web of Science ®Google Scholar
• Nakazato P, Victorino J, Fina C, et al. Liver ischemia and reperfusion injury. Pathophysiology and new horizons in preconditioning and therapy. Acta Cir Bras. 2018;33(8):723–735. doi:10.1590/s0102-865020180080000008
   PubMed Web of Science ®Google Scholar
• Marinho H, Marcelino P, Soares H, Corvo M. Gene silencing using siRNA for preventing liver ischaemia-reperfusion injury. Curr Pharm Design. 2018;24(23):2692–2700. doi:10.2174/1381612824666180807124356
   PubMed Web of Science ®Google Scholar
• Dossi C, Vargas R, Valenzuela R, Videla L. Beneficial effects of natural compounds on experimental liver ischemia-reperfusion injury. Food Funct. 2021;12(9):3787–3798. doi:10.1039/d1fo00289a
   PubMed Web of Science ®Google Scholar
• Grayer R, Eckert M, Veitch N, et al. The chemotaxonomic significance of two bioactive caffeic acid esters, nepetoidins A and B, in the Lamiaceae. Phytochemistry. 2003;64(2):519–528. doi:10.1016/s0031-9422(03)00192-4
   PubMed Web of Science ®Google Scholar
• Kim M, Kim J, Yang H, Choe J, Hwang I. Salvia plebeia Nepetoidin B from R. Br. inhibits inflammation by modulating the NF-κB and Nrf2/HO-1 signaling pathways in macrophage cells. Antioxidants-Basel. 2021;10(8). doi:10.3390/antiox10081208
   Web of Science ®Google Scholar
• Wu X, Gao H, Sun W, et al. Nepetoidin B, a natural product, inhibits LPS-stimulated nitric oxide production via modulation of iNOS mediated by NF-κB/MKP-5 pathways. Phytother Res. 2017;31(7):1072–1077. doi:10.1002/ptr.5828
   PubMed Web of Science ®Google Scholar
• Yu B, Zhang Y, Wang T, et al. MAPK signaling pathways in hepatic ischemia/reperfusion injury. J Inflamm Res. 2023;16:1405–1418. doi:10.2147/JIR.S396604
   PubMed Web of Science ®Google Scholar
• Bi J, Zhang J, Ke M, et al. HSF2BP protects against acute liver injury by regulating HSF2/HSP70/MAPK signaling in mice. Cell Death Dis. 2022;13(9):830. doi:10.1038/s41419-022-05282-x
   PubMed Web of Science ®Google Scholar
• Jiménez-Martínez M, Stamatakis K, Fresno M. The Dual-Specificity Phosphatase 10 (DUSP10): its role in cancer, inflammation, and immunity. Int J Mol Sci. 2019;20(7):1626. doi:10.3390/ijms20071626
   PubMed Web of Science ®Google Scholar
• Theodosiou A, Smith A, Gillieron C, Arkinstall S, Ashworth A. MKP5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases. Oncogene. 1999;18(50):6981–6988. doi:10.1038/sj.onc.1203185
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang M, Zhang J, Xia Q. A novel mouse model of liver ischemic/reperfusion injury and its differences to the existing model. J Invest Surg. 2015;28(5):283–291. doi:10.3109/08941939.2014.983621
   PubMed Web of Science ®Google Scholar
• Yu Q, Chen S, Tang H, et al. Veratric acid alleviates liver ischemia/reperfusion injury by activating the Nrf2 signaling pathway. Int Immunopharmacol. 2021;101:108294. doi:10.1016/j.intimp.2021.108294
   PubMed Web of Science ®Google Scholar
• Serrano E, Diaz J, Acosta F, Palenciano C, Parrilla P, Carbonell L. Oxidative stress during ischemia-reperfusion in liver transplantation. Transpl P. 2000;32(8):2651. doi:10.1016/s0041-1345(00)01824-8
   PubMed Web of Science ®Google Scholar
• Shen Y, Shen X, Cheng Y, Liu Y. Myricitrin pretreatment ameliorates mouse liver ischemia reperfusion injury. Int Immunopharmacol. 2020;89:107005. doi:10.1016/j.intimp.2020.107005
   PubMed Web of Science ®Google Scholar
• Ye J, Peng J, Liu K, Zhang T, Huang W. MCTR1 inhibits ferroptosis by promoting NRF2 expression to attenuate hepatic ischemia-reperfusion injury. Am J Physiol Gastr Liver Physiol. 2022;323(3):G283–G293. doi:10.1152/ajpgi.00354.2021
   PubMed Web of Science ®Google Scholar
• Fernandes D, Gonçalves R, Laurindo F. Measurement of superoxide production and NADPH oxidase activity by HPLC analysis of dihydroethidium oxidation. Methods Mol Biol. 2017;1527:233–249. doi:10.1007/978-1-4939-6625-7_19
   PubMedGoogle Scholar
• Li J, Li J, Fang H, et al. Isolongifolene alleviates liver ischemia/reperfusion injury by regulating AMPK-PGC1α signaling pathway-mediated inflammation, apoptosis, and oxidative stress. Int Immunopharmacol. 2022;113:109185. doi:10.1016/j.intimp.2022.109185
   PubMed Web of Science ®Google Scholar
• Kahan R, Cray P, Abraham N, et al. Sterile inflammation in liver transplantation. Front Med Lausanne. 2023;10:1223224. doi:10.3389/fmed.2023.1223224
   PubMed Web of Science ®Google Scholar
• Liu Y, Sheng M, Jia L, Zhu M, Yu W. Protective effects of cordycepin pretreatment against liver ischemia/reperfusion injury in mice. Immun Inflamm Dis. 2023;11(3):e792. doi:10.1002/iid3.792
   PubMed Web of Science ®Google Scholar
• Sun Q, Gong J, Gong X, et al. Long non-coding RNA MALAT1 aggravated liver ischemia-reperfusion injury via targeting miR-150-5p/AZIN1. Bioengineered. 2022;13(5):13422–13436. doi:10.1080/21655979.2022.2073124
   PubMed Web of Science ®Google Scholar
• Kim E, Choi E. Compromised MAPK signaling in human diseases: an update. Arch Toxicol. 2015;89(6):867–882. doi:10.1007/s00204-015-1472-2
   PubMed Web of Science ®Google Scholar
• Liang Y, Yang W. Kinesins in MAPK cascade: how kinesin motors are involved in the MAPK pathway? Gene. 2019;684:1–9. doi:10.1016/j.gene.2018.10.042
   PubMed Web of Science ®Google Scholar
• Guo W, Fang H, Cao S, et al. Six-transmembrane epithelial antigen of the prostate 3 deficiency in hepatocytes protects the liver against ischemia-reperfusion injury by suppressing transforming growth factor-β-activated kinase 1. Hepatology. 2020;71(3):1037–1054. doi:10.1002/hep.30882
   PubMed Web of Science ®Google Scholar
• Zhou J, Guo L, Ma T, et al. N-acetylgalactosaminyltransferase-4 protects against hepatic ischemia/reperfusion injury by blocking apoptosis signal-regulating kinase 1 N-terminal dimerization. Hepatology. 2022;75(6):1446–1460. doi:10.1002/hep.32202
   PubMed Web of Science ®Google Scholar
• Qian F, Deng J, Cheng N, et al. A non-redundant role for MKP5 in limiting ROS production and preventing LPS-induced vascular injury. EMBO J. 2009;28(19):2896–2907. doi:10.1038/emboj.2009.234
   PubMed Web of Science ®Google Scholar
• Qian F, Deng J, Gantner B, et al. Map kinase phosphatase 5 protects against sepsis-induced acute lung injury. Am J Physiol-Lung C. 2012;302(9):L866–L874. doi:10.1152/ajplung.00277.2011
   PubMed Web of Science ®Google Scholar
• Pinzi L, Rastelli G. Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci. 2019;20(18). doi:10.3390/ijms20184331
   PubMed Web of Science ®Google Scholar
• Yu Q, Chen S, Li J, et al. Mitogen activated protein kinase phosphatase 5 alleviates liver ischemia-reperfusion injury by inhibiting TAK1/JNK/p38 pathway. Sci Rep. 2023;13(1):11110. doi:10.1038/s41598-023-37768-9
   PubMed Web of Science ®Google Scholar